Earnings Call Summary | Darling Ingredients(DAR.US) Q1 2024 Earnings Conference
Earnings Call Summary | Darling Ingredients(DAR.US) Q1 2024 Earnings Conference
The following is a summary of the Darling Ingredients Inc. (DAR) Q1 2024 Earnings Call Transcript:
以下是達令原料公司（DAR）2024年第一季度業績電話會議記錄摘要：
Financial Performance:
財務業績：
Darling Ingredients reported a Q1 2024 net income of $81.2 million, a decrease from Q1 2023's report of $185.8 million.
Net sales for Q1 2024 were $1.42 billion, a decrease when compared to Q1 2023's $1.79 billion.
Operating income decreased to $137.2 million for Q1 2024 from the $255.8 million reported in Q1 2023. This was accompanied by a decrease in gross margin by $120.6 million.
達令原料公佈的2024年第一季度淨收入爲8,120萬美元，低於2023年第一季度的1.858億美元。
2024年第一季度的淨銷售額爲14.2億美元，與2023年第一季度的17.9億美元相比有所下降。
營業收入從2023年第一季度公佈的2.558億美元降至2024年第一季度的1.372億美元。與此同時，毛利率下降了1.206億美元。
Business Progress:
業務進展：
The company has completed the acquisition of Miropasz, adding three poultry rendering plants to their portfolio.
The reopening of the company's Ward South Carolina rendering plant is expected to provide much-needed capacity in the Eastern United States.
They've identified a portfolio of collagen peptide profiles set to provide health and wellness benefits for new product launches.
They are also ahead of schedule in the construction of their sustainable aviation unit, estimated to start operations in Q4 2024.
Future strategies include potential share repurchases and possible dividends by 2025. Future investments may also include a prospective SAF 2 project slated for 2025, subject to improving margins and returns.
該公司已經完成了對Miropasz的收購，在其投資組合中增加了三家家禽養殖廠。
該公司南卡羅來納州沃德渲染廠的重新開放預計將爲美國東部提供急需的產能。
他們已經確定了一系列膠原蛋白肽組合，旨在爲新產品的發佈提供健康和保健益處。
他們還提前建造了可持續航空部門，預計將於2024年第四季度開始運營。
未來的策略包括潛在的股票回購和到2025年可能的分紅。未來的投資還可能包括定於2025年實施的潛在SAF 2項目，但前提是利潤率和回報率有所提高。
More details: Darling Ingredients IR
更多詳情： 親愛的食材 IR
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：欲了解更多詳情，請訪問投資者關係網站。本文僅供投資者參考，不構成任何投資建議。
譯文內容由第三人軟體翻譯。